Source:http://linkedlifedata.com/resource/pubmed/id/16024000
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-8-1
|
pubmed:abstractText |
Oleuropein, a non-toxic secoiridoid derived from the olive tree, is a powerful antioxidant and anti-angiogenic agent. Here, we show it to be a potent anti-cancer compound, directly disrupting actin filaments in cells and in a cell-free assay. Oleuropein inhibited the proliferation and migration of advanced-grade tumor cell lines in a dose-responsive manner. In a novel tube-disruption assay, Oleuropein irreversibly rounded cancer cells, preventing their replication, motility, and invasiveness; these effects were reversible in normal cells. When administered orally to mice that developed spontaneous tumors, Oleuropein completely regressed tumors in 9-12 days. When tumors were resected prior to complete regression, they lacked cohesiveness and had a crumbly consistency. No viable cells could be recovered from these tumors. These observations elevate Oleuropein from a non-toxic antioxidant into a potent anti-tumor agent with direct effects against tumor cells. Our data may also explain the cancer-protective effects of the olive-rich Mediterranean diet.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Actins,
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic,
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrans,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Glucosidase,
http://linkedlifedata.com/resource/pubmed/chemical/oleuropein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-291X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
334
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
769-78
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16024000-Actins,
pubmed-meshheading:16024000-Angiogenesis Inhibitors,
pubmed-meshheading:16024000-Animals,
pubmed-meshheading:16024000-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:16024000-Antioxidants,
pubmed-meshheading:16024000-Cell Migration Inhibition,
pubmed-meshheading:16024000-Cell Proliferation,
pubmed-meshheading:16024000-Cytoskeleton,
pubmed-meshheading:16024000-Humans,
pubmed-meshheading:16024000-Mice,
pubmed-meshheading:16024000-Neoplasm Invasiveness,
pubmed-meshheading:16024000-Olea,
pubmed-meshheading:16024000-Pyrans,
pubmed-meshheading:16024000-Tumor Cells, Cultured,
pubmed-meshheading:16024000-beta-Glucosidase
|
pubmed:year |
2005
|
pubmed:articleTitle |
Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor.
|
pubmed:affiliation |
H2RC Corporation, 1920 E. Katella Avenue, Suite U, Orange, CA 92867, USA. hkhamdi@gmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|